Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungbong Han

Showing results (171-180 of 179) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 179 results.
BMC Gastroenterology|May 1, 2013
Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean populationYoung-Joo Jin, Jin-Woo Lee, Jung Il Lee, et al.
The American Journal of Cardiology|March 20, 2012
Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularizationYong-Giun Kim, Duk-Woo Park, Woo Seok Lee, et al.
The American Journal of Cardiology|August 5, 2018
Fate of Grafts Bypassing Nonischemic Versus Ischemic Inducing Coronary StenosisJae-Hyung Roh, Young-Hak Kim, Dong Hyun Yang, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trialJung-Min Ahn, Duk-Woo Park, Young-Hak Kim, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trialYoung-Suk Lim, Ming-Lung Yu, Jonggi Choi, et al.
Circulation|October 8, 2013
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trialCheol Whan Lee, Jung-Min Ahn, Duk-Woo Park, et al.
Circulation|December 3, 2014
Response to letter regarding article, "optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial"Seung-Jung Park, Cheol Whan Lee, Jung-Min Ahn, et al.
Circulation|March 1, 2019
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total OcclusionSeung-Whan Lee, Pil Hyung Lee, Jung-Min Ahn, et al.
Eclinicalmedicine|June 17, 2024
Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007-2021: a nationwide, multicentre, retrospective cohort studyWon Sohn, Soo Young Park, Tae Hee Lee, et al.
Pageof 18

Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
BMC Gastroenterology|May 1, 2013
Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean populationYoung-Joo Jin, Jin-Woo Lee, Jung Il Lee, et al.
The American Journal of Cardiology|March 20, 2012
Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularizationYong-Giun Kim, Duk-Woo Park, Woo Seok Lee, et al.
The American Journal of Cardiology|August 5, 2018
Fate of Grafts Bypassing Nonischemic Versus Ischemic Inducing Coronary StenosisJae-Hyung Roh, Young-Hak Kim, Dong Hyun Yang, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trialJung-Min Ahn, Duk-Woo Park, Young-Hak Kim, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trialYoung-Suk Lim, Ming-Lung Yu, Jonggi Choi, et al.
Circulation|October 8, 2013
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trialCheol Whan Lee, Jung-Min Ahn, Duk-Woo Park, et al.
Circulation|December 3, 2014
Response to letter regarding article, "optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial"Seung-Jung Park, Cheol Whan Lee, Jung-Min Ahn, et al.
Circulation|March 1, 2019
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total OcclusionSeung-Whan Lee, Pil Hyung Lee, Jung-Min Ahn, et al.
Eclinicalmedicine|June 17, 2024
Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007-2021: a nationwide, multicentre, retrospective cohort studyWon Sohn, Soo Young Park, Tae Hee Lee, et al.
Pageof 18